Tectonic Therapeutic, Inc.
TECXHealthcareNASDAQBiotechnology
Scan Results
Daily timeframePart of the healthcare sector, Tectonic Therapeutic, Inc. (TECX) is listed under Biotechnology. The $392.4M market capitalization puts TECX squarely in small-cap range for its industry. It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines.
Market Cap
$392.4M
Beta
0.38
P/E (TTM)
—
P/E (Fwd)
-4.22
EPS (TTM)
$-4.57
EPS (Fwd)
$-4.76
ROE
-33.8%
ROA
-22.3%
Cash
$227.1M
Total Debt
$4.4M
Free CF
-$46.7M
52W Change
7.8%
Annual Financials
Cash vs Debt
Where TECX stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, TECX finished 30.54% below its 150-day moving average ($29.73) and 26.43% below its 200-day moving average ($28.07). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is TECX overbought or oversold?
At the October 19, 2026 close, TECX's RSI(14) was 28.1, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $227.1M in cash and $4.4M in debt, TECX maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$46.7M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -33.8%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits.
TECX's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. With cash comfortably exceeding debt, TECX has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing TECX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.